GlassScriptPhysician profile
Scott A Thurman
NPI 1043206436
$37,846.96
in general payments reported to CMS, 2019-2025
37 companies · $21K in 2025
The $21K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,112 · 2020: $394 · 2021: $662 · 2022: $524 · 2023: $734 · 2024: $14K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $29K · Travel and Lodging: $2,779 · Food and Beverage: $2,762 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Grant: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $29,000.00 |
| Travel and Lodging | $2,779.19 |
| Food and Beverage | $2,761.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Grant | $113.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $33,512.30 | 2024-2025 | |
| Abbvie INC. | $737.43 | 2019-2025 | Lupron Depot, Botox |
| Boston Scientific Corporation | $512.79 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue |
| Neotract INC. | $490.38 | 2019-2020 | |
| Astellas Pharma US INC | $292.15 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $243.25 | 2019-2024 | Erleada |
| Dendreon Pharmaceuticals LLC | $184.60 | 2020-2023 | Provenge |
| Merck Sharp & Dohme LLC | $155.63 | 2021-2024 | Keytruda, Welireg, Lynparza |
| Axonics, INC. | $141.99 | 2022-2024 | Bulkamid |
| Urogen Pharma, INC. | $130.72 | 2020-2024 | Jelmyto |
| Myovant Sciences INC. | $127.06 | 2021-2022 | |
| Innovation Technologies INC | $109.15 | 2023 | Irrisept |
| Olympus America INC. | $104.11 | 2024-2025 | Itind System |
| Ferring Pharmaceuticals INC. | $98.48 | 2019 | |
| Blue Earth Diagnostics | $88.30 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $88.10 | 2023 | |
| Progenics Pharmaceuticals, INC. | $82.46 | 2022-2024 | Pylarify |
| Genzyme Corporation | $78.37 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $75.02 | 2019-2022 | |
| Teleflex LLC | $66.83 | 2021-2023 | Urolift |
| Ethicon US, LLC | $60.37 | 2019-2023 | Vistaseal, Stratafix |
| Bayer Healthcare Pharmaceuticals INC. | $57.56 | 2020-2023 | |
| Endo Pharmaceuticals INC. | $57.12 | 2020-2022 | |
| Cook Medical LLC | $50.12 | 2024-2025 | Resonance |
| Sumitomo Pharma America, INC. | $46.90 | 2023 | Orgovyx |
| Coloplast Corp | $42.18 | 2021-2022 | |
| Davol INC. | $36.11 | 2025 | |
| Angiodynamics, INC. | $25.05 | 2024 | Nanoknife |
| Amgen INC. | $20.66 | 2019 | |
| Travere Therapeutics, INC. | $20.45 | 2021 | |
| Healthtronics Stone Solutions, LLC | $19.49 | 2019 | |
| Covidien LP | $19.44 | 2019 | |
| 180 Medical, INC. | $18.44 | 2019 | |
| Procept Biorobotics Corporation | $14.80 | 2025 | |
| Myriad Genetic Laboratories, INC. | $13.80 | 2023 | Prolaris |
| Medtronic, INC. | $13.70 | 2023 | Interstim |
| Mission Pharmacal Company | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Thurman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.